Revilla, Jolina .
HRN: 28-98-98 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2025
CEFTRIAXONE 1G (VIAL)
10/26/2025
11/02/2025
IV
2g
OD
DENGUE FEVER
Checking Final Appropriateness